Consonance Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Consonance Capital Partners has invested in 2 companies.

Consonance Capital Partners’ most common sectors for investment arehealthcare services (45%) and life science (34%) . The Firm’s most common investment types include recapitalization (45%) and divestiture (23%). In total, Consonance Capital Partners has invested in 6 US states.

The Firm’s most common exit type is trade sale (80%). Consonance Capital Partners’ largest (disclosed) exit occurred in 2019 when it sold Corindus Vascular Robotics for $1.1B.

Join Mergr to view Consonance Capital Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity9
    • M&A Sell Activity5
  • Total Sectors Invested 4
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 6
  • M&A Advisors 4

Consonance Capital Partners

1370 Avenue of the Americas, 33rd Floor,
New York, New York 10019
United States
(212) 660-8060
www.consonancecapital.com/private-capital-for-the-middle-market/
contactus@consonancecapital.com

Consonance Capital Partners is a healthcare-focused private investment firm focused on both public and private equity investing. The Firm's private equity group targets growth equity, leveraged buyouts, and recapitalization transactions in lower middle-market companies with $25 to $500 million of revenue. Specific areas of interest include healthcare providers, mayors, distribution, medical devices, specialty pharmaceuticals, outsourced services, and healthcare IT. Consonance Capital Partners was formed in 2005 and is based in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 25 500
Target EBITDA - -
Investment Size - -
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # 7 - 1 1 - - 9
Sell (0.2/yr) # 4 1 - - - - 5
vol $1.1B $1.1B
  14

Most Recent M&A

Company Date Value Type
Orsini Specialty Pharmacy 2022-02-11 - Growth Capital
Elk Grove Village, Illinois · www.orsinispecialtypharmacy.com
Surrozen, Inc. 2021-04-15 - PIPE
South San Francisco, California · www.surrozen.com
Turn-Key Health 2020-05-04 - Trade Sale
Philadelphia, Pennsylvania · www.turn-keyhealth.com
Enclara Healthcare 2019-12-16 - Trade Sale
Philadelphia, Pennsylvania · www.enclarahealthcare.com
Enclara Pharmacia, Inc. 2019-12-16 - Trade Sale
Philadelphia, Pennsylvania · www.excellerx.com
Corindus Vascular Robotics, Inc. 2019-08-08 1.1B USD Trade Sale
Waltham, Massachusetts · www.corindus.com
Sellers Dorsey & Associates LLC 2019-05-22 - Recapitalization
Philadelphia, Pennsylvania · www.sellersdorsey.com
Orsini Pharmaceutical Services 2019-02-06 - Recapitalization
Elk Grove Village, Illinois · www.orsinihealthcare.com
Psychiatric Medical Care 2018-12-21 - Recapitalization
Nashville, Tennessee · www.psychmc.com
Keystone Peer Review Organization, Inc. 2017-05-30 - Secondary Sale
Nashville, Tennessee · www.kepro.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 2 (33%) - 4 (44%) -
Life Science 3 (50%) - 3 (33%) -
Business Services 1 (17%) - 1 (11%) -
Medical Products - - 1 (11%) -
Total 6 - 9 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 6 (100%) - 9 (100%) -
  Illinois 2 (33%) - 2 (22%) -
  Tennessee 1 (17%) - 2 (22%) -
  Pennsylvania 1 (17%) - 2 (22%) -
  Georgia 1 (17%) - 1 (11%) -
  California 1 (17%) - 1 (11%) -
  Massachusetts - - 1 (11%) -
Total 6 - 9 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Recapitalization 4 (67%) - 4 (44%) -
Divestiture - - 2 (22%) -
Going Private - - 1 (11%) -
Growth Capital 1 (17%) - 1 (11%) -
PIPE 1 (17%) - 1 (11%) -
Total 6 - 9 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 3 (60%) 1.1B (100%)
Secondary Sale 1 (20%) -
Trade Sale 1 (20%) -
Total 5 $1.1B

Top M&A Advisors

Financial Deals
Evercore Group
2
Legal Deals
Latham & Watkins
6
Bass, Berry & Sims PLC
2
Foley & Lardner LLP
1

Deal Values

sell # Total
> $1B 1 $1.1B
TOTAL $1.1B
Largest Corindus Vascular Robotics, Inc.
$1.1B (2019-08-08)

M&A Connections

Deals
Acquired from
Investor(s)
11%
1 (11%)
Strategic(s)
22%
2 (22%)
Exited to
Investor(s)
20%
1 (20%)
Strategic(s)
80%
4 (80%)

FAQ

When was Consonance Capital Partners founded?

Consonance Capital Partners was founded in 2005.

What type of investor is Consonance Capital Partners?

Consonance Capital Partners is a private equity firm.

Where is Consonance Capital Partners headquartered?

Consonance Capital Partners is headquartered in New York, New York.

How much capital does Consonance Capital Partners have under management?

Consonance Capital Partners has 1.3B USD under management.

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.